Skip to main content
Clinical Trials/EUCTR2017-002169-23-DK
EUCTR2017-002169-23-DK
Active, Not Recruiting
Phase 1

The effect of clinical characterization of children with monosymptomatic nocturnal enuresis on the efficacy of desmopressin and alarm therapy. - DRYCHILD

Søren Rittig0 sites400 target enrollmentJune 30, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Enuresis nocturna
Sponsor
Søren Rittig
Enrollment
400
Status
Active, Not Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 30, 2017
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Søren Rittig

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 6\-14 years.
  • 2\. Three or more wet nights per week regarding the home registrations.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 400
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. Ongoing constipation and/or faecal incontinence.
  • 2\. Daytime symptoms such as urgency, frequency or incontinence.
  • 3\. Recurrent urinary tract infections.
  • 4\. Anamnestic, clinical or laboratory findings that can be related to diseases or conditions that might affect the parameters investigated.
  • 5\. Neurological and/or known clinically significant anatomical abnormalities of the urinary tract.
  • 6\. Former operations in the urinary tract.
  • 7\. Prior or ongoing treatment with alarm, desmopressin or anticholinergics.
  • 8\. Ongoing medication that may interfere with the parameters tested.
  • 9\. Pregnant or lactating girl.
  • 10\. Contra\-indications for the use of desmopressin: habitual or psychogenic polydipsia, use of diuretics, renal insufficiency, hyponatraemia or SIADH.

Outcomes

Primary Outcomes

Not specified

Similar Trials